These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1474418)

  • 1. The role of exercise in reducing coronary heart disease and associated risk factors.
    Leclerc KM
    J Okla State Med Assoc; 1992 Jun; 85(6):283-90. PubMed ID: 1474418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly.
    Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW
    Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of coronary heart disease and risk factors in an urban Indian population: Jaipur Heart Watch-2.
    Gupta R; Gupta VP; Sarna M; Bhatnagar S; Thanvi J; Sharma V; Singh AK; Gupta JB; Kaul V
    Indian Heart J; 2002; 54(1):59-66. PubMed ID: 11999090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strategies for the prevention of coronary heart disease: a policy statement of the European Atherosclerosis Society.
    Eur Heart J; 1987 Jan; 8(1):77-88. PubMed ID: 3816842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of lifestyle changes on atherogenic lipids and endothelial cell adhesion molecules in young adults with familial premature coronary heart disease.
    Tonstad S; Sundfør T; Seljeflot I
    Am J Cardiol; 2005 May; 95(10):1187-91. PubMed ID: 15877991
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk determination of dyslipidemia in populations characterized by low levels of high-density lipoprotein cholesterol.
    Bersot TP; Pépin GM; Mahley RW
    Am Heart J; 2003 Dec; 146(6):1052-9. PubMed ID: 14660998
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between serum lipids and causes of mortality in a cohort of 3,499 urban Thais: The Electricity Generating Authority of Thailand (EGAT) study.
    Sritara P; Patoomanunt P; Woodward M; Narksawat K; Tulyadachanon S; Ratanachaiwong W; Sritara C; Barzi F; Yamwong S; Tanomsup S
    Angiology; 2007 Dec-2008 Jan; 58(6):757-63. PubMed ID: 18216384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease.
    Gotto AM
    Am Heart J; 2002 Dec; 144(6 Suppl):S33-42. PubMed ID: 12486414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors of Hong Kong Chinese patients with coronary heart disease.
    Chair SY; Lee SF; Lopez V; Ling EM
    J Clin Nurs; 2007 Jul; 16(7):1278-84. PubMed ID: 17584346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of physical activity on lipid and lipoprotein levels.
    Goldberg L; Elliot DL
    Med Clin North Am; 1985 Jan; 69(1):41-55. PubMed ID: 3883078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Greek adolescents, fitness, fatness, fat intake, activity, and coronary heart disease risk.
    Bouziotas C; Koutedakis Y; Nevill A; Ageli E; Tsigilis N; Nikolaou A; Nakou A
    Arch Dis Child; 2004 Jan; 89(1):41-4. PubMed ID: 14709501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors predicting improvements in lipid values following cardiac rehabilitation and exercise training.
    Lavie CJ; Milani RV
    Arch Intern Med; 1993 Apr; 153(8):982-8. PubMed ID: 8481069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choice and use of blood lipid tests. An epidemiologic perspective.
    Hulley SB; Lo B
    Arch Intern Med; 1983 Apr; 143(4):667-73. PubMed ID: 6340621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipids, lipoproteins and apolipoproteins among turks, and impact on coronary heart disease.
    Onat A
    Anadolu Kardiyol Derg; 2004 Sep; 4(3):236-45. PubMed ID: 15355827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds: a meta-analysis of randomized controlled trials.
    Birjmohun RS; Hutten BA; Kastelein JJ; Stroes ES
    J Am Coll Cardiol; 2005 Jan; 45(2):185-97. PubMed ID: 15653014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reducing the risk of coronary heart disease via lipid reduction.
    Spratt KA
    J Am Osteopath Assoc; 2004 Sep; 104(9 Suppl 7):S9-13. PubMed ID: 15467018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the detection of high-risk lipoprotein profiles and the treatment of dyslipoproteinemias. Canadian Lipoprotein Conference Ad Hoc Committee on Guidelines for Dyslipoproteinemias.
    CMAJ; 1990 Jun; 142(12):1371-82. PubMed ID: 2190685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dyslipidemia and coronary artery disease.
    Genest JG
    Can J Cardiol; 2000 Jan; 16 Suppl A():3A-4A. PubMed ID: 10653923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of physical activity on plasma levels of lipids and lipoproteins in patients with coronary disease].
    Da Silva MJ; Netto MP; Kedor HH; Camargo PA; Kiss MA; Giannini SD; Deperon SD
    Arq Bras Cardiol; 1988 Apr; 50(4):231-6. PubMed ID: 3067692
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.